Abstract
A simple, specific, accurate and economical isocratic reversed phase liquid chromatographic (RP‐HPLC) method was developed and subsequently validated for the determination of paracetamol, acetyl salicylic acid, mefenamic acid and cetirizine dihydrochloride. Separation was achieved with a Nucleodur 100 C–18 column having 250 × 4.6 mm i.d. with 5 µm particle size and disodium hydrogen phosphate buffer adjusted to pH 6.5 using diluted orthophosphoric acid and acetonitrile (60:40 v∕v) as eluent at a constant flow rate of 1.0 mL per min. UV detection was performed at 220 nm. The retention time of acetyl salicylic acid, paracetamol, mefenamic acid and cetirizine dihydrochloride were 2.01 min, 2.92 min, 4.91 min and 10.2 min respectively. This method is simple, rapid and selective and can be used for routine analysis of analgesic and antipyretic drugs in pharmaceutical formulations. The proposed method was validated and successfully used for estimation of paracetamol, acetyl salicylic acid, mefenamic acid and cetirizine dihydrochloride in the pharmaceutical dosage form.
Highlights
Analysis is an integral component of preformulation, formulation and active ingredient drug development research
Paracetamol, acetyl salicylic acid, mefenamic acid and cetirizine dihydrochloride is official in pharmacopoeias and HPLC method had been reported for its estimation
This paper describes a new RP- HPLC method for the estimation of paracetamol, acetyl salicylic acid, mefenamic acid and cetirizine dihydrochloride combination in mixture using simple mobile phase
Summary
Analysis is an integral component of preformulation, formulation and active ingredient drug development research. Paracetamol, acetyl salicylic acid, mefenamic acid and cetirizine dihydrochloride is official in pharmacopoeias and HPLC method had been reported for its estimation. This paper describes a new RP- HPLC method for the estimation of paracetamol, acetyl salicylic acid, mefenamic acid and cetirizine dihydrochloride combination in mixture using simple mobile phase.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.